Transforming Growth Factor β Inhibits MUC5AC Expression by Smad3/HDAC2 Complex Formation and NF-κB Deacetylation at K310 in NCI-H292 Cells
Su Ui Lee,Mun-Ock Kim,Myung-Ji Kang,Eun Sol Oh,Hyunju Ro,Ro Woon Lee,Yu Na Song,Sunin Jung,Jae-Won Lee,Soo Yun Lee,Taeyeol Bae,Sung-Tae Hong,Tae-Don Kim
DOI: https://doi.org/10.14348/molcells.2020.0188
2021-01-31
Molecules and Cells
Abstract:Airway mucus secretion is an essential innate immune response for host protection. However, overproduction and hypersecretion of mucus, mainly composed of the gel- forming MUC5AC protein, are significant risk factors for patients with asthma and chronic obstructive pulmonary disease (COPD). The transforming growth factor β (TGFβ) signaling pathway negatively regulates MUC5AC expression; however, the underlying molecular mechanism is not fully understood. Here, we showed that TGFβ significantly reduces the expression of <i>MUC5AC</i> mRNA and its protein in NCI-H292 cells, a human mucoepidermoid carcinoma cell line. This reduced <i>MUC5AC</i> expression was restored by a TGFβ receptor inhibitor (SB431542), but not by the inhibition of NF-κB (BAY11-7082 or Triptolide) or PI3K (LY294002) activities. TGFβ-activated Smad3 dose-dependently bound to <i>MUC5AC</i> promoter. Notably, TGFβ-activated Smad3 recruited HDAC2 and facilitated nuclear translocation of HDAC2, thereby inducing the deacetylation of NF-κB at K310, which is essential for a reduction in NF-κB transcriptional activity. Both TGFβ-induced nuclear translocation of Smad3/HDAC2 and deacetylation of NF-κB at K310 were suppressed by a Smad3 inhibitor (SIS3). These results suggest that the TGFβ-activated Smad3/HDAC2 complex is an essential negative regulator for <i>MUC5AC</i> expression and an epigenetic regulator for NF-κB acetylation. Therefore, these results collectively suggest that modulation of the TGFβ1/Smad3/HDAC2/NF-κB pathway axis can be a promising way to improve lung function as a treatment strategy for asthma and COPD.
cell biology,biochemistry & molecular biology